Ati cautat: boli rare la copii

Scenarii epidemiologice – masuri sanitare si de protectie in scoli

INSP – Reactualizarea Definitiilor de caz pentru Sindromul respirator acut cu noul coronavirus (Covid-19)

Protocol terapeutic: N03AX23 – DCI BRIVARACETAMUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: M05BX05 – DCI BUROSUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L04AX06 – DCI POMALIDOMIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L04AA10 – DCI SIROLIMUS (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L01XX27 – DCI ARSENICUM TRIOXIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L01XC32 – DCI ATEZOLIZUMAB (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L01XC16 – DCI DINUTUXIMAB BETA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: A16AX03 – DCI NATRII PHENYLBUTYRATE (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)